Details for New Drug Application (NDA): 019434
✉ Email this page to a colleague
The generic ingredient in TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is cimetidine hydrochloride. There are twenty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cimetidine hydrochloride profile page.
Summary for 019434
Tradename: | TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER |
Applicant: | Glaxosmithkline |
Ingredient: | cimetidine hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 6MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Oct 31, 1985 | TE: | RLD: | Yes |
Expired US Patents for NDA 019434
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | cimetidine hydrochloride | INJECTABLE;INJECTION | 019434-001 | Oct 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | cimetidine hydrochloride | INJECTABLE;INJECTION | 019434-001 | Oct 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | cimetidine hydrochloride | INJECTABLE;INJECTION | 019434-001 | Oct 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription